Haverford Trust CO Bristol Myers Squibb CO Transaction History

Haverford Trust CO

  • $10.2 Billion
  • Q3 2024

A detailed history of Haverford Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Haverford Trust CO holds 67,229 shares of BMY stock, worth $3.88 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
67,229
Previous 66,847 0.57%
Holding current value
$3.88 Million
Previous $2.78 Million 25.32%
% of portfolio
0.03%
Previous 0.03%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$39.66 - $51.75 $15,150 - $19,768
382 Added 0.57%
67,229 $3.48 Million
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $195,977 - $258,008
-4,869 Reduced 6.79%
66,847 $2.78 Million
Q1 2024

May 02, 2024
SELL
$47.98 - $54.4 $313,069 - $354,960
-6,525 Reduced 8.34%
71,716 $3.89 Million
Q4 2023

Feb 08, 2024
BUY
$48.48 - $57.85 $73,592 - $87,816
1,518 Added 1.98%
78,241 $4.01 Million
Q3 2023

Nov 09, 2023
SELL
$57.89 - $64.73 $355,097 - $397,053
-6,134 Reduced 7.4%
76,723 $4.45 Million
Q2 2023

Aug 08, 2023
SELL
$63.71 - $70.74 $92,889 - $103,138
-1,458 Reduced 1.73%
82,857 $5.3 Million
Q1 2023

May 12, 2023
SELL
$65.71 - $74.53 $20,238 - $22,955
-308 Reduced 0.36%
84,315 $5.84 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $206,056 - $243,999
-3,009 Reduced 3.43%
84,623 $6.09 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $432 - $255,416
-3,324 Reduced 3.65%
87,632 $6.23 Million
Q2 2022

Aug 12, 2022
BUY
$72.62 - $79.98 $39,723 - $43,749
547 Added 0.61%
90,956 $7 Million
Q1 2022

May 05, 2022
BUY
$61.48 - $73.72 $444,561 - $533,069
7,231 Added 8.69%
90,409 $6.6 Million
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $122,919 - $143,295
-2,292 Reduced 2.68%
83,178 $5.19 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $58,696 - $68,755
-992 Reduced 1.15%
85,470 $5.06 Million
Q2 2021

Aug 16, 2021
BUY
$61.91 - $67.42 $5 Million - $5.44 Million
80,685 Added 1396.66%
86,462 $5.78 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $4.77 Million - $5.19 Million
-77,008 Reduced 93.02%
5,777 $5.78 Million
Q1 2021

May 12, 2021
SELL
$59.34 - $66.74 $187,099 - $210,431
-3,153 Reduced 3.67%
82,785 $5.23 Million
Q4 2020

Feb 05, 2021
BUY
$57.74 - $65.43 $305,271 - $345,928
5,287 Added 6.56%
85,938 $5.33 Million
Q3 2020

Nov 10, 2020
BUY
$57.43 - $63.64 $50,997 - $56,512
888 Added 1.11%
80,651 $4.86 Million
Q2 2020

Aug 13, 2020
SELL
$54.82 - $64.09 $118,356 - $138,370
-2,159 Reduced 2.64%
79,763 $4.69 Million
Q1 2020

May 11, 2020
BUY
$46.4 - $67.43 $38,094 - $55,360
821 Added 1.01%
81,922 $4.57 Million
Q4 2019

Feb 10, 2020
BUY
$49.21 - $64.19 $279,414 - $364,470
5,678 Added 7.53%
81,101 $5.21 Million
Q3 2019

Nov 04, 2019
SELL
$42.77 - $50.71 $100,723 - $119,422
-2,355 Reduced 3.03%
75,423 $3.83 Million
Q2 2019

Aug 13, 2019
BUY
$44.62 - $49.34 $1,383 - $1,529
31 Added 0.04%
77,778 $3.53 Million
Q1 2019

May 09, 2019
BUY
$45.12 - $53.8 $71,018 - $84,681
1,574 Added 2.07%
77,747 $3.71 Million
Q4 2018

Feb 12, 2019
SELL
$48.76 - $63.23 $201,330 - $261,076
-4,129 Reduced 5.14%
76,173 $3.96 Million
Q3 2018

Nov 08, 2018
SELL
$55.19 - $62.25 $68,545 - $77,314
-1,242 Reduced 1.52%
80,302 $4.99 Million
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $256,136 - $319,245
-5,069 Reduced 5.85%
81,544 $4.51 Million
Q1 2018

May 09, 2018
BUY
$59.92 - $68.98 $258,434 - $297,510
4,313 Added 5.24%
86,613 $5.48 Million
Q4 2017

Feb 13, 2018
BUY
$59.94 - $65.35 $243,835 - $265,843
4,068 Added 5.2%
82,300 $5.04 Million
Q3 2017

Nov 09, 2017
BUY
$55.23 - $63.74 $152,434 - $175,922
2,760 Added 3.66%
78,232 $4.99 Million
Q2 2017

Aug 14, 2017
BUY
N/A
75,472
75,472 $4.21 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Haverford Trust CO Portfolio

Follow Haverford Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email